News Releases:

2008

miRagen Therapeutics Chief Scientific Advisor wins the American Heart Association National Research Achievement Award

Award Recognizes Groundbreaking Research Unveiling the Genetic Blueprint for Heart and Cardiovascular System Development and Disease November 13, 2008 01:00 PM Eastern Time BOULDER, Colo.–(BUSINESS WIRE)–miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough... View »

miRagen Therapeutics, Inc. and Collaborators Publish Study Identifying microRNA Perturbations Following Acute Myocardial Infarction

Results identify miR-29 as a key regulator of cardiac fibrosis September 02, 2008 09:01 AM Eastern Time BOULDER, Colo.–(BUSINESS WIRE)–miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease... View »

Miragen Therapeutics, Inc. Receives $8 M in Venture Capital Financing for Development of MicroRNA-based Therapies

May 19, 2008 09:00 AM Eastern Time BOULDER, Colo.–(BUSINESS WIRE)–Miragen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced the completion of an... View »